HOME >> BIOLOGY >> NEWS
Chemical warfare ravages mental health of Iranian civilians

Iranian civilians exposed to high-intensity warfare and chemical weapons are experiencing significantly higher levels of psychological distress compared to those exposed to low-intensity warfare but not chemical weapons, researchers at Yale School of Medicine report in the August 2 issue of the Journal of the American Medical Association devoted to the theme of violence and human rights.

The research was based on data collected in July 2004 on 153 civilians in three towns bordering Iran and Iraq by researchers in the Department of Epidemiology and Public Health (EPH) at Yale School of Medicine, the Department of Psychiatry and the VA Connecticut Healthcare System.

The team, led by EPH research associate Farnoosh Hashemian, conducted a cross-sectional randomized study to measure civilian trauma during the Iran-Iraq war, which lasted from 1980 to 1988, caused one million casualties on both sides and 60,000 chemical warfare survivors in Iran. While much is known about the physical consequences of chemical warfare, the researchers sought to document the long-term effects of chemical attacks on mental health.

During two months in Iran, the team examined war-related mental health problems in three towns. One town was exposed to conventional low-intensity warfare, another was exposed to high-intensity warfare and the third, Sardasht, was exposed to both high-intensity warfare and chemical warfare. The team conducted 90-minute face-to-face interviews with residents and measured post-traumatic stress disorder (PTSD), anxiety and depression.

Those who were exposed to both high-intensity warfare and chemical weapons had significantly higher mental health disorders than did residents of the other two towns. Fifty-nine percent of Sardasht residents were found to have experienced PTSD in their lifetime. Thirty-three percent were currently suffering from PTSD, 65 percent reported major anxiety symptoms and 41 percent had severe dep
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
1-Aug-2006


Page: 1 2

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. American Chemical Society meets Aug. 19-23 in Boston
3. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
4. News tips from ACS Chemical Biology
5. American Chemical Societys Weekly PressPac -- July 25, 2007
6. American Chemical Societys Weekly PressPac -- July 18, 2007
7. American Chemical Societys Weekly PressPac -- July 11, 2007
8. Wiley extends publishing partnership with the American Institute of Chemical Engineers
9. American Chemical Societys Weekly PressPac -- June 27/July 3, 2007
10. News tips from ACS Chemical Biology
11. American Chemical Societys Weekly PressPac -- June 20, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... Aug. 23, 2017  The general public,s help is being enlisted in ... that live in and on the human body –and are believed to ... The Microbiome Immunity Project ... microbiome, starting with the gut. The project's goal is to help advance ... IBM ...
(Date:6/23/2017)... N.Y. and ITHACA, N.Y. ... ) and Cornell University, a leader in dairy research, ... with bioinformatics designed to help reduce the chances that ... With the onset of this dairy project, Cornell University ... Consortium for Sequencing the Food Supply Chain, a food ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree ... products targeting the needs of consumers who are incorporating medical marijuana into their ... Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s ...
Breaking Biology Technology:
Cached News: